Lilach
Lilach Agemy, Santa Barbara, CA US
Patent application number | Description | Published |
---|---|---|
20110262347 | METHODS AND COMPOSITIONS FOR ENHANCED DELIVERY OF COMPOUNDS - Disclosed are compositions and methods related to multivalent compositions targeted to cells and tissues. The disclosed targeting is useful for treatment of cancer and other diseases and disorders. | 10-27-2011 |
Lilach Agemy, La Jolla, CA US
Patent application number | Description | Published |
---|---|---|
20110165064 | METHODS AND COMPOSITIONS RELATED TO CLOT-BINDING COMPOUNDS - Disclosed are compositions and methods related to clot-binding compounds. For example, disclosed are compositions comprising a surface molecule and at least one modified clot-binding compound. The modified clot-binding compound can selectively bind to clotted plasma protein, wherein the composition causes clotting and amplifies the accumulation of the composition in tumors. The modified clot-binding compound can enhance the clotting in tumors compared to its unmodified derivative. The disclosed targeting is useful for treatment of cancer and other diseases and disorders. | 07-07-2011 |
Lilach Armony-Shimoni, Haifa IL
Patent application number | Description | Published |
---|---|---|
20090021576 | Panoramic image production - A method of assembling a panoramic image from a plurality of frames in a camera, the method comprising: (a) acquiring a video stream using a camera; (b) selecting an initial frame from the video stream for capture as a still image; (c) further selecting additional frames; and (d) stitching the additional frames to the initial frame in the camera to create a panoramic image. | 01-22-2009 |
Lilach Bien, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20130211797 | SYSTEM AND METHOD FOR ANALYZING GIS DATA TO IMPROVE OPERATION AND MONITORING OF WATER DISTRIBUTION NETWORKS - A computerized method for modeling a utility network. The method includes retrieving geographical information system (GIS) data, asset management data, and sensor archive data of one or more assets of the utility network. The method also includes generating one or more mathematical elements from the one or more assets and creating probable connections between the one or more mathematical graph elements based on the GIS and asset data. A mathematical graph is generated based on the probable connections, the mathematical graph including one or more asset characteristics of the one or more assets. Analysis is performed on the utility network using the mathematical graph and the mathematical graph data is stored for use by other systems within the utility network. | 08-15-2013 |
20130332090 | SYSTEM AND METHOD FOR IDENTIFYING RELATED EVENTS IN A RESOURCE NETWORK MONITORING SYSTEM - A computerized method for detecting related events in a water monitoring system. The method includes receiving event data from a plurality of sensors in a water network. The method also includes identifying at least two candidate events from the event data as being candidate events which are likely to constitute part of a common anomaly event, the candidate events each being substantially anomalous. An event combination rule is selected. One or more event characteristics are compared between the at least two candidate events based on the event combination rule. The at least two candidate events are determined whether they are related and associated with a common event causing the at least two candidate events on the basis of the comparison. The determination of the at least two candidate events are related and associated with a common event is reported to a user via a user interface. | 12-12-2013 |
20130332397 | METHOD FOR LOCATING A LEAK IN A FLUID NETWORK - Methods and systems are described for providing cost effective leak detection in a fluid network. Step testing procedures are represented by decision trees and associated expected costs are calculated. Selection of step testing procedures is optimized for low expected cost. The total expected cost rate for a network configuration may be calculated from the rate of leak occurrence and the optimal expected costs associated therewith. Network configuration changes may be recommended by optimizing for total expected cost rate for a fluid network. | 12-12-2013 |
Lilach Hedvati, Ein-Shemer IL
Patent application number | Description | Published |
---|---|---|
20090209603 | Olmesartan medoxomil with reduced levels of impurities - The present invention provides the preparation of olmesartan medoxomil containing less than about 0.1% of one or more of the impurities OLM-Me, OLM-Cl, and OLM-eliminate. | 08-20-2009 |
20100087525 | STEREOSELECTIVE ENZYMATIC SYNTHESIS OF (S) OR (R)-ISO-BUTYL-GLUTARIC ESTER - The present invention relates to a stereoselective enzymatic synthesis of (S) or (R)-iso-butyl-glutaric ester, an intermediate of S-Pregabalin. | 04-08-2010 |
20100184987 | Preparation of Retapamulin via its Pleuromutilin-thiol precursor - Provided are processes for preparation of Retapamulin via its pleuromutilin-thiol precursor. | 07-22-2010 |
Lilach Hedvati, Doar Na Hefer IL
Patent application number | Description | Published |
---|---|---|
20090137842 | PREGABALIN -4-ELIMINATE, PREGABALIN 5-ELIMINATE, THEIR USE AS REFERENCE MARKER AND STANDARD, AND METHOD TO PRODUCE PREGABALIN CONTAINING LOW LEVELS THEREOF - The present invention provides 3-(aminomethyl)-5-methylhex-4-enoic acid (Pregabalin-4-eliminate or PRG-4E) and 3-(aminomethyl)-5-methylhex-5-enoic acid (Pregabalin-5-eliminate or PRG-5E), and their uses as reference markers and standards for determining the purity of Pregabalin. The invention also provides a method to produce Pregabalin containing low levels of these impurities. | 05-28-2009 |
20090149655 | Process for the preparation of Retapamulin and its intermediates - Processes for preparing tropine derivatives of the following Formula B | 06-11-2009 |
20090234125 | Amorphous retapamulin and processes for preparation thereof - An amorphous form of Retapamulin, preferably in powder form, and processes for preparation thereof, are provided. Amorphous Retapamulin of the present invention can contain less than about 10 percent crystallinity, preferably less than about 5 percent crystallinity. Pharmaceutical compositions comprising amorphous Retapamulin are also provided. | 09-17-2009 |
20100076200 | Purification of olmesartan medoxomil - The present invention provides a process for purifying olmesartan medoxomil. | 03-25-2010 |
20130079360 | RALTEGRAVIR SALTS AND CRYSTALLINE FORMS THEREOF - The present invention includes new salts of Raltegravir and crystalline forms thereof, pharmaceutical compositions containing the salts or crystalline forms, methods of using the salts or crystalline forms or the compositions to treat HIV infection or to prepare medicament for treating HIV infection, and a process for preparing Raltegravir potassium. | 03-28-2013 |
20130096147 | Raltegravir Salts and Crystalline Forms Thereof - The present invention includes new salts of Raltegravir and crystalline forms thereof, pharmaceutical compositions containing the salts or crystalline forms, methods of using the salts or crystalline forms or the compositions to treat HIV infection or to prepare medicament for treating HIV infection, and a process for preparing Raltegravir potassium. | 04-18-2013 |
20140256755 | Raltegravir Salts And Crystalline Forms Thereof - The present invention includes new salts of Raltegravir and crystalline forms thereof, pharmaceutical compositions containing the salts or crystalline forms, methods of using the salts or crystalline forms or the compositions to treat HIV infection or to prepare medicament for treating HIV infection, and a process for preparing Raltegravir potassium. | 09-11-2014 |
Lilach Mandeles, Nirit IL
Patent application number | Description | Published |
---|---|---|
20080306877 | Secure Internet E-Commerce - A secure Internet based website electronically facilitating Internet entry of an account-owner to a pre-registered account on the secure Internet based website; escorting the owner to a merchant Internet site and therewith transmitting to the merchant site a one-time password, wherein said one-time password is thereafter identifiable by the secure Internet based website; receiving an invoice from the merchant Internet site wherein said invoice includes the one-time password; validating the one-time password; and presenting the invoice to the account owner. Now, if the secure Internet site receives an invoice approval from the owner, then the secure Internet site electronically providing the merchant Internet site with payment and delivery details necessary to complete a commercial agreement between the owner and the merchant wherein said agreement corresponds to specification, terms, and conditions associated with the invoice. | 12-11-2008 |
Lilach Mousseiri, San Mateo, CA US
Patent application number | Description | Published |
---|---|---|
20110265248 | SPORTS TYPE HELMET INTEGRATABLE WITH SMOKE DETECTOR - A sporting type helmet with a smoke detector. The sporting type helmet features a partial shell defining a portion of a complete helmet. The partial shell is curved and is three-dimensional. The partial shell forms a concave cavity configured to engage around an outer periphery of said smoke detector so as to cover said smoke detector. The partial shell also includes an aperture or helmet button on said partial shell for conducting periodical testing of the smoke detector. The partial shell also includes a plurality of vents that permit smoke to reach the smoke detector. The partial shell also incorporates a speaker that can issue audible sounds upon testing or operation of the smoke detector. | 11-03-2011 |
Lilach Tencer, Rehovot IL
Patent application number | Description | Published |
---|---|---|
20100235150 | THERAPEUTIC IMPLICATIONS OF DICKKOPF AFFECTING CANCER STEM CELL FATE - A method of determining a therapeutic regimen for the treatment of cancer with Dickkopf (Dkk) protein in which a mathematical model of differential equations describing the major signaling pathways involved in stem cell regulation is created and used to simulate signals from the cancer stem cell environment based upon administration of at least a single dose of Dkk in vitro and/or in vivo. A method of modulating cancer stem cells is also provided in which the stem cell computer model is simulates the effect of Dkk and performs a calibration test to determine a threshold value above which Dkk induces cell differentiation and a threshold value below which Dkk induces stem cell proliferation. | 09-16-2010 |